Use of Diuretics in Heart Failure and Cirrhosis

This publication has 37 references indexed in Scilit:

• Hyperkalemia: a threat to RAAS inhibition?
  Nature Reviews Nephrology, 2010
• Oral Tolvaptan Is Safe and Effective in Chronic Hyponatremia
  Journal of the American Society of Nephrology, 2010
• Renal Failure in Cirrhosis
  New England Journal of Medicine, 2009
• Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)
  American Heart Journal, 2005
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
  New England Journal of Medicine, 1999
• Effectiveness of Spironolactone Added to an Angiotensin-Converting Enzyme Inhibitor and a Loop Diuretic for Severe Chronic Congestive Heart Failure (The Randomized Aldactone Evaluation Study [RALES])**See Appendix for full list of RALES investigators.
  The American Journal of Cardiology, 1996
• Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor
  The American Journal of Cardiology, 1993
• Aldosterone in Congestive Heart Failure: Analysis of Determinants and Role in Sodium Retention
  American Journal of Nephrology, 1991
• Radioimmunoassay of Plasma Arginine Vasopressin in Hyponatremic Patients with Congestive Heart Failure
  New England Journal of Medicine, 1981
• A Method for the Detection and Quantification of Impaired Sodium Excretion
  Circulation, 1965